Literature DB >> 10942736

The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation.

S Wang1, S S Leonard, J Ye, M Ding, X Shi.   

Abstract

The present study investigates whether reactive oxygen species (ROS) are involved in p53 activation, and if they are, which species is responsible for the activation. Our hypothesis is that hydroxyl radical (.OH) functions as a messenger for the activation of this tumor suppressor protein. Human lung epithelial cells (A549) were used to test this hypothesis. Cr(VI) was employed as the source of ROS due to its ability to generate a whole spectrum of ROS inside the cell. Cr(VI) is able to activate p53 by increasing the protein levels and enhancing both the DNA binding activity and transactivation ability of the protein. Increased cellular levels of superoxide radicals (O(2)(-).), hydrogen peroxide (H(2)O(2)), and.OH radicals were detected on the addition of Cr(VI) to the cells. Superoxide dismutase, by enhancing the production of H(2)O(2) from O(2)(-). radicals, increased p53 activity. Catalase, an H(2)O(2) scavenger, eliminated.OH radical generation and inhibited p53 activation. Sodium formate and aspirin,.OH radical scavengers, also suppressed p53 activation. Deferoxamine, a metal chelator, inhibited p53 activation by chelating Cr(V) to make it incapable of generating radicals from H(2)O(2). NADPH, which accelerated the one-electron reduction of Cr(VI) to Cr(V) and increased.OH radical generation, dramatically enhanced p53 activation. Thus.OH radical generated from Cr(VI) reduction in A549 cells is responsible for Cr(VI)-induced p53 activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942736     DOI: 10.1152/ajpcell.2000.279.3.C868

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  35 in total

Review 1.  Cell apoptosis induced by carcinogenic metals.

Authors:  F Chen; V Vallyathan; V Castranova; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

2.  NF-kappaB prevents cells from undergoing Cr(VI)-induced apoptosis.

Authors:  Suwei Wang; Fei Chen; Zhuo Zhang; Bing-hua Jiang; Luo Jia; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

3.  Toxicity of depleted uranium complexes is independent of p53 activity.

Authors:  Ellie Heintze; Camille Aguilera; Malia Davis; Avery Fricker; Qiang Li; Jesse Martinez; Matthew J Gage
Journal:  J Inorg Biochem       Date:  2010-10-29       Impact factor: 4.155

4.  Cr(VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells.

Authors:  Young-Ok Son; J Andrew Hitron; Xin Wang; Qingshan Chang; Jingju Pan; Zhuo Zhang; Jiankang Liu; Shuxia Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-16       Impact factor: 4.219

5.  p53 mediates particulate matter-induced alveolar epithelial cell mitochondria-regulated apoptosis.

Authors:  Saul Soberanes; Vijayalakshmi Panduri; Gökhan M Mutlu; Andrew Ghio; G R Scott Bundinger; David W Kamp
Journal:  Am J Respir Crit Care Med       Date:  2006-08-31       Impact factor: 21.405

Review 6.  Molecular and epigenetic mechanisms of Cr(VI)-induced carcinogenesis.

Authors:  Qiao Yi Chen; Anthony Murphy; Hong Sun; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-20       Impact factor: 4.219

Review 7.  Molecular mechanisms of Cr(VI)-induced carcinogenesis.

Authors:  Min Ding; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Doxorubicin-induced apoptosis: implications in cardiotoxicity.

Authors:  B Kalyanaraman; Joy Joseph; Shashi Kalivendi; Suwei Wang; Eugene Konorev; Srigiridhar Kotamraju
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Generation of reactive oxygen species in the enzymatic reduction of PbCrO4 and related DNA damage.

Authors:  Stephen S Leonard; Val Vallyathan; Vince Castranova; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 10.  Doxorubicin cardiomyopathy.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Joel S Karliner
Journal:  Cardiology       Date:  2009-12-11       Impact factor: 1.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.